G1 Therapeutics

6 email addresses found for g1therapeutics.com
{first}@g1therapeutics.com
6 email addresses
http://apnews.com/52d34bbbd1074d7f239f66c34a708550 January 1, 2019
http://apnews.com/5d90c1938f54633e9c80fb974668d1a6 January 1, 2019
http://apnews.com/88a772ef5bd45cf1606e889a87b85394 January 1, 2019
http://apnews.com/8bcd88e3318d4b36d9a03aa0ecb623bf January 1, 2019
http://apnews.com/97ec880c90f5243ed76e24ad74d74671 January 1, 2019
http://benzinga.com/pressreleases/18/06/g11819102/g1-therapeutics-presents-phase-1b-data-on-g1t38-in-combination-with-fa January 1, 2019
http://cnbc.com/2018/03/07/globe-newswire-g1-therapeutics-announces-pricing-of-offering-of-common-stock.html December 12, 2018
http://cnbc.com/2018/03/12/globe-newswire-g1-therapeutics-announces-closing-of-offering-of-common-stock.html January 1, 2019
http://g1therapeutics.gcs-web.com/news-releases/news-release-details/g1-therapeutics-announces-positive-myelopreservation-data January 1, 2019
http://g1therapeutics.gcs-web.com/news-releases/news-release-details/preliminary-results-randomized-phase-2-trial-demonstrate January 1, 2019
http://hatterasvp.com/g1-therapeutics-announces-pricing-of-offering-of-common-stock August 8, 2018
http://hatterasvp.com/g1-therapeutics-expands-executive-leadership-team-with-appointment-of-john-demaree-as-chief-commercial-officer-and-stillman-hanson-as-general-counsel August 8, 2018
http://health.einnews.com/pr_news/447319955/g1-therapeutics-to-present-phase-1b-data-on-g1t38-in-combination-with-faslodex-for-treatment-of-breast-cancer-at-2018-american-society-of-clinical January 1, 2019
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-appointment-garry-nicholson-board January 1, 2019
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-closing-offering-common-stock January 1, 2019
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-closing-offering-common-stock-0 January 1, 2019
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-initiation-phase-1b2-clinical-trial January 1, 2019
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-positive-myelopreservation-data January 1, 2019
http://lumiraventures.com/g1-therapeutics-announces-appointment-of-new-members-to-the-board-of-directors August 8, 2018
http://lumiraventures.com/g1-therapeutics-announces-closing-of-offering-of-common-stock August 8, 2018
http://lumiraventures.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-benefits-in-patients-with-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-expands-executive-leadership-team-with-appointment-of-john-demaree-as-chief-commercial-officer-and-stillman-hanson-as-general-counsel August 8, 2018
http://mtngp.com/g1-therapeutics-announces-initiation-of-phase-1b-2-clinical-trial-of-g1t38-in-combination-with-tagrisso-for-egfr-mutant-non-small-cell-lung-cancer July 7, 2018
http://mtngp.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer April 4, 2018
http://nasdaq.com/press-release/g1-therapeutics-presents-additional-data-from-randomized-phase-2-trial-of-trilaciclib-in-20181021-00017 January 1, 2019
http://news.durhamonline.us/press-releases/g1-therapeutics-announces-appointment-of-garry-nicholson-to-board-of-directors-200930 January 1, 2019
http://news.durhamonline.us/press-releases/g1-therapeutics-announces-closing-of-offering-of-common-stock-202974 January 1, 2019
http://tmcnet.com/usubmit/2018/11/07/8848215.htm December 12, 2018
http://tmcnet.com/usubmit/2018/12/04/8861893.htm January 1, 2019
http://unique.finance/g1-therapeutics-presents-phase-1b-data-on-g1t38-in-combination-with-faslodex-for-treatment-of-breast-cancer-at-2018-american-society-of-clinical-oncology-asco-annual-meeting June 6, 2018
http://cnbc.com/2015/02/02/globe-newswire-g1-therapeutics-to-present-at-17th-annual-bio-ceo-investor-conference.html January 1, 2019
http://cnbc.com/2015/08/05/globe-newswire-g1-therapeutics-to-present-at-august-investor-conferences.html January 1, 2019
http://cnbc.com/2015/09/03/globe-newswire-g1-therapeutics-to-present-at-september-biotech-conferences.html January 1, 2019
http://cnbc.com/2015/10/21/globe-newswire-glenn-p-muir-appointed-to-g1-therapeutics-board-of-directors.html December 12, 2018
http://cnbc.com/2015/11/10/globe-newswire-g1-therapeutics-to-present-at-the-stifel-2015-healthcare-conference.html January 1, 2019
http://g1therapeutics.com/pages/news/releases/031615.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/040815.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/041515.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/052715.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/061015.htm June 6, 2015
http://hatterasvp.com/g1-therapeutics-raises-33-million-in-series-b-financing May 5, 2016
http://hatterasvp.com/g1-therapeutics-secures-47-million-series-c-financing May 5, 2016
http://hatterasvp.com/g1-therapeutics-to-evaluate-trilaciclib-g1t28-in-combination-with-immune-checkpoint-inhibitor-in-small-cell-lung-cancer January 1, 2017
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-announces-presentations-2017-american November 11, 2018
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-present-bio-international-convention November 11, 2018
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-present-clinical-and-preclinical-data-cdk46 November 11, 2018
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-present-positive-clinical-and-preclinical-data November 11, 2018
http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-present-september-biotech-conferences November 11, 2018
http://life-sciences-europe.com/news/therapeutics-raises-million-series-inc-nasdaq-gthx-medimmune-2001-110998.html October 10, 2017
http://life-sciences-europe.com/news/therapeutics-secures-million-series-inc-nasdaq-gthx-cormorant-2001-110999.html October 10, 2017
http://lumiraventures.com/g1-therapeutics-announces-initiation-of-two-phase-1b2a-trials-of-cdk46-inhibitor-g1t28-in-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-secures-47-million-series-c-financing August 8, 2018
http://lumiraventures.com/g1-therapeutics-to-evaluate-trilaciclib-g1t28-in-combination-with-immune-checkpoint-inhibitor-in-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-to-present-positive-clinical-and-preclinical-data-on-cdk46-inhibitor-g1t28 August 8, 2018
http://lumiraventures.com/glenn-p-muir-appointed-to-g1-therapeutics-board-of-directors August 8, 2018
http://mgcfund.com/g1-therapeutics-secures-47-million-series-c-financing July 7, 2016
http://mtngp.com/g1-therapeutics-announces-presentations-2017-american-association-cancer-research-annual-meeting April 4, 2018
http://mtngp.com/g1-therapeutics-initiates-three-drug-development-programs-breast-cancer March 3, 2017
http://mtngp.com/g1-therapeutics-secures-47-million-series-c-financing November 11, 2016
Show more results

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about g1therapeutics.com

Language of the website: English

Main technologies used: